Osivax

Osivax
Osivax
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies based on its proprietary technology oligoDOM® inducing powerful CD8 T-cell responses
?
Osivax was created as a spin-off of Imaxio, a commercial-stage vaccine company, in order to accelerate the development of oligoDOM® technology platform
Lyon
Vaccines, Technology, Biotech
2017
http://www.osivax.com/

Articles about Osivax:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Osivax? We’re happy to assist you with our Startup Sourcing service.